Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.
We have studied the effect of plasminogen activator inhibitors PAI-1 and PAI-2 on the binding of urokinase-type plasminogen activator (u-PA) to its receptor in the human choriocarcinoma cell line JAR. With 125I-labeled ligands in whole-cell binding assays, both uncomplexed u-PA and u-PA-inhibitor co...
Guardat en:
| Publicat a: | Cell Regul |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Cell Biology
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC361701/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1966892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1091/mbc.1.13.1043 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|